Yes, in many cases you can. UK prescribing information allows adults on the 2.4 mg weekly Wegovy injection to move to the 25 mg daily Wegovy pill, starting the tablets one week after the last injection. A prescriber has to approve the switch, and the tablet comes with strict rules about how it is taken.
At a glance
Who can switch directly: adults taking the 2.4 mg weekly injection.
When to start the pill: seven days after the final injection, which is the day the next one would have been due.
Lower injection doses or the 7.2 mg dose: the licence gives no conversion, so your prescriber decides.
How to take it: on an empty stomach with a sip of water, then wait 30 minutes before food, drink or other tablets.
How to get it: on prescription only. Private UK pharmacies now supply it after a consultation, and NHS access is not available yet, pending a NICE assessment.
This guide covers how the switch works, what changes day to day, and how to buy Wegovy pills online through a regulated pharmacy.
What Is the Wegovy Pill, and How Does It Differ from the Injection?
The Wegovy pill (semaglutide 25 mg tablets) is a once-daily tablet with the same active ingredient as the Wegovy injection. Semaglutide is a GLP-1 receptor agonist, a medicine that copies a gut hormone involved in appetite and fullness.
The MHRA licensed the tablet on 11 June 2026, making it the first GLP-1 tablet licensed in the UK for weight management. It is approved, alongside a reduced-calorie diet and more physical activity, for adults with a BMI of 30 or above. It is also approved for a BMI from 27 to 29.9 with at least one weight-related condition, such as high blood pressure or type 2 diabetes. There are no data for under 18s, so the switch applies to adults only.
Two practical differences sit outside the table. Unopened pens need keeping in a fridge before first use. The tablets have no special temperature requirement, only their original blister pack to protect them from moisture and light. The injection is also given once a week at any time of day, with or without food. The tablet’s daily routine is far less flexible.
What Does UK Prescribing Information Say About Switching?
The tablet’s Summary of Product Characteristics (SmPC) is the document that sets out how a medicine is licensed to be used. It describes one route. Patients treated with the 2.4 mg weekly injection can move to the 25 mg tablet once daily, starting one week after their last injection. When the tablet was approved, the MHRA said private patients on 2.4 mg could be transitioned directly to the tablets.
The SmPC also carries a caution. It says the effect of switching between the two forms cannot easily be predicted, because tablet absorption varies more from person to person. The figures show what that means. At steady state, the average semaglutide level on 25 mg tablets is about 77 nmol/L, close to the 75 nmol/L seen on the 2.4 mg injection. But 90% of people on the tablet fell between 27 and 186 nmol/L, against 51 to 110 nmol/L on the injection. The averages match. The spread does not.
How Do You Switch from 2.4 mg Injections to 25 mg Tablets?
-
Book a consultation. You need a new prescription because the tablets are a separate product. The prescriber will review your medical history, current medicines and how you have coped with the injections.
-
Take your final injection on your usual day. Carry on as normal until the prescriber confirms the plan.
-
Wait seven days. Take no tablet during this week.
-
Start the 25 mg tablet on the day your next injection would have been due. If you normally inject on Sundays, your first tablet is the following Sunday morning.
-
Take one tablet a day. Never double up, and never use the tablets and the injections together.
-
Review after about a month. Semaglutide reaches steady levels four to five weeks after daily tablets begin, so this is a fair point to judge appetite, side effects and weight with your prescriber.
The licence does not ask people on 2.4 mg to repeat the 1.5 mg, 4 mg and 9 mg steps first. In individual cases a prescriber may choose a slower start, for example for someone prone to nausea. That is a clinical decision, not a licence instruction.
Supply gaps matter too. If tablets are out of stock when your seven days end, tell your prescriber rather than waiting it out. In the STEP 1 extension, people who stopped semaglutide for a year regained weight, although they stayed 5.6% below their starting weight on average.
What If You Take a Lower Injection Dose or the 7.2 mg Dose?
The SmPC gives no conversion for anyone below 2.4 mg. It gives none for the higher dose either. Adults with obesity can have their injection dose raised to 7.2 mg after at least four weeks on 2.4 mg, and the STEP UP trial found this reduced weight more than 2.4 mg did. No tablet goes above 25 mg.
A 25 mg tablet and a 2.4 mg injection are not comparable on paper, so you cannot work out an equivalent by matching numbers. A prescriber has to use clinical judgement. That might mean starting part-way up the tablet ladder, or at 1.5 mg to keep side effects down. Neither approach is written into the licence. Please do not swap doses yourself.
Why Are the Wegovy Pill Doses So Much Higher Than the Injection Doses?
A 25 mg tablet next to a 2.4 mg injection looks like a tenfold jump. It is not, because far less of the tablet reaches your blood.
Semaglutide is a peptide, and the stomach breaks most of it down. The tablet contains an absorption enhancer, salcaprozate sodium (often called SNAC), which helps semaglutide cross the stomach lining. Even so, only about 1% to 2% of each tablet is absorbed. An injection skips the digestive system altogether.
That gap explains the larger numbers on the packet. It also explains the fasting rules, because the SmPC says absorption falls when the tablet is taken with food or large volumes of water. Taking a second tablet to make up for poor absorption is not allowed. The maximum is one tablet a day.
How Do You Take the Wegovy Pill Correctly?
Follow the routine every day. Waiting less than 30 minutes before eating or drinking reduces how much semaglutide you absorb. In practice, this means taking it first thing in the morning.
-
Take it after an overnight fast of at least eight hours.
-
Swallow it whole with a sip of plain water, up to half a glass (120 ml).
-
Do not split, crush or chew it.
-
Wait at least 30 minutes before eating, drinking or taking other oral medicines. Tea and coffee count as drinks.
-
Take one tablet a day, at about the same time.
-
If you miss a dose, skip it and take the next tablet the following day.
-
Leave tablets in the blister pack until you need them.
Morning routines are where most people run into trouble. Semaglutide slows stomach emptying, which can affect how other tablets are absorbed. If you take levothyroxine, warfarin or anything else that needs precise timing, speak to your prescriber or pharmacist before switching. In one study, thyroxine exposure rose by 33% after a single levothyroxine dose, and the SmPC suggests considering thyroid monitoring. It also recommends frequent INR checks when semaglutide is started in people on warfarin.
Semaglutide has a half-life of about a week, so one missed tablet does not empty your system overnight. Regularly ignoring the fasting rules is different. Over weeks, it lowers the amount you absorb.
Does the Wegovy Pill Work as Well as the Injection?
In separate trials, the results are close. The two forms have not been tested head to head, so treat the comparison as indirect.
Source: UK SmPC for Wegovy 25 mg tablets, last updated 16 June 2026.
Three points give those numbers context.
-
Size and length. OASIS 4 involved 307 adults, against 1,961 in STEP 1, and ran four weeks shorter.
-
Heart outcomes. The SELECT trial enrolled adults with established cardiovascular disease and overweight or obesity, but without diabetes. Over a median follow-up of about three and a half years, major cardiovascular events occurred in 6.5% of people on the injection and 8.0% on placebo (hazard ratio 0.80). That evidence comes from the injection. OASIS 4 was not designed to measure cardiovascular events.
-
Absorption. The SmPC warns that if the response to the tablet is lower than expected, variable absorption may be part of the reason, so sticking to the dosing routine matters.
What Side Effects Can You Expect After Switching?
Both forms cause the same main side effects, mostly digestive. The SmPC describes them as mostly mild to moderate, short-lived and most frequent while doses are being increased.
Placebo groups had symptoms too. Nausea affected 18.6% of the placebo group in OASIS 4, so not every symptom comes from the medicine itself. Indigestion was also very common on the tablet. Hair loss was reported by 6.4% of tablet users against 2.0% on placebo, and 4.9% reported altered skin sensation such as tingling or sensitive skin.
There is one honest gap. The SmPC admits the effect of a switch is hard to predict, so nobody can promise how your first fortnight will feel. Note what you notice and tell your prescriber.
Get medical help straight away if you have:
-
persistent, severe abdominal pain, which can signal pancreatitis
-
sudden loss of vision, even partial
-
signs of dehydration, such as being unable to keep fluids down, dizziness on standing or passing very little urine
-
swelling of the face, lips or throat, or difficulty breathing (call 999)
Report suspected side effects through the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk. The tablet carries the black triangle symbol, meaning it is under additional monitoring, so reports are particularly useful.
Who Should Speak to a Prescriber Before Switching?
Everyone should, but these situations need particular care.
-
Pregnancy, breastfeeding or trying for a baby. The tablets should not be used in pregnancy or while breastfeeding. Women who could become pregnant are advised to use contraception, and semaglutide should be stopped at least two months before a planned pregnancy.
-
A history of pancreatitis. Use with caution. If pancreatitis is confirmed during treatment, semaglutide should not be restarted.
-
Gastroparesis. Digestive effects can be more severe, and the tablets are not recommended when gastroparesis is severe.
-
Severe kidney or liver disease. The tablets are not recommended in severe kidney impairment (eGFR below 30) or severe liver impairment.
-
Type 2 diabetes. Insulin or sulfonylurea doses may need reducing to avoid low blood sugar, and people with diabetic retinopathy need close monitoring.
-
Planned surgery or sedation. Delayed stomach emptying raises the risk of stomach contents entering the lungs under general anaesthesia or deep sedation, so tell your anaesthetist.
-
A current or past eating disorder. Pharmacies are expected to give specific consideration to eating disorders when reviewing clinical suitability.
Should You Switch or Stay on the Injection?
There is no universal answer. It depends on your routine, your response so far and how well you can keep to the tablet’s rules.
The pill may suit you if:
-
You dislike needles or get reactions at injection sites
-
You are steady on 2.4 mg and prefer a daily habit to a weekly one
-
Storing and carrying pens is awkward for you
-
You can keep the same morning routine every day
The injection may suit you better if:
-
Your mornings cannot fit an overnight fast and a 30-minute wait, for example, because of shift work
-
You take other morning medicines that must be timed precisely, such as levothyroxine
-
You are on the 7.2 mg dose
-
The SELECT heart outcomes evidence matters to your decision
-
Your prescriber wants to avoid the wider absorption variation seen with tablets
Can You Switch Back from the Pill to the Injection?
Sometimes, with the same prescriber-led care. The tablet’s UK prescribing information sets out the route from injection to tablet only. It gives no equivalent route back. The injection’s SmPC carries the same warning that the effect of switching between the two forms cannot easily be predicted. So do not assume that 25 mg tablets equal a restart at 2.4 mg injections. Your prescriber will choose the dose and timing.
How Much Does the Wegovy Pill Cost Compared with the Injection?
Private prices vary by pharmacy and strength, and they change often. One price comparison published in September 2026 found 25 mg tablets listed from about £170 a month, with other pharmacies at £180 to £190. A separate comparison of injection pens put the average listed price of a 2.4 mg pen at about £209, with the lowest around £186. Each pen covers four weekly doses. At maintenance dose the two sit in a similar bracket, so price rarely settles the choice on its own.
Before you pay, check three things:
-
What the price includes. Consultation, prescribing, delivery and support costs may or may not be built into the advertised price.
-
Whether an introductory offer ends. Most tablet offers apply to the first order only.
-
Whether the price is for your long-term strength. Starter tablets cost less than 25 mg tablets.
On the NHS, NICE has recommended the Wegovy injection only within specialist weight management services, for a maximum of two years. It applies to adults with at least one weight-related condition and a BMI of 35 or above, or 30 to 34.9 if referral criteria are met. The pill is not part of that recommendation yet. NICE has reopened its assessment of oral semaglutide for weight management, and NHS use will depend on the outcome. Prices and NHS status move quickly, so check current details before you decide.
How Can You Buy Wegovy Pill Online in the UK Safely?
Wegovy is a prescription-only medicine, so no legitimate website can sell it without a clinical assessment. If a site hands over tablets or pens after a tick-box form and a card payment, walk away. This is what a properly regulated purchase looks like.
-
Confirm the pharmacy is registered. Search for the pharmacy and its superintendent pharmacist on the General Pharmaceutical Council (GPhC) register. A logo on its own proves nothing, so click through to the register entry.
-
Complete a genuine consultation. Expect detailed questions about your weight, medical history, medicines, pregnancy plans and eating habits.
-
Expect identity and measurement checks. GPhC guidance expects pharmacies to confirm identity using recognised digital identity standards. The prescriber must independently verify your height, weight or BMI, for example by video consultation, from clinical records or through your GP. A phone call or a photo on its own is not considered enough.
-
Accept the prescriber’s decision. They may decline or ask you to see your GP first. That is the system working, not an obstacle.
-
Check what arrives. Genuine supplies come in UK packaging with a patient information leaflet, and the pharmacy should give you a route for questions and dose changes.
Red flags
-
no prescriber and no consultation
-
claims that no prescription is needed
-
sellers on social media, marketplaces or messaging apps
-
pens or tablets with no UK packaging or leaflet
-
prices far below every other pharmacy
The MHRA has repeatedly warned that products from social media sellers and unregulated sites may be counterfeit or contaminated. If you come across an online provider operating unsafely, you can report it to the GPhC through its “Report a concern” service. Tell your GP about any weight-loss medicine you take, wherever you got it.
Is It Safe to Buy Wegovy Injections Online?
It is, provided the same checks are in place. They are identical whether you are starting, continuing or restarting after a break. A pharmacy that skips them is not following GPhC guidance, and its pens may not be genuine. If you are moving to tablets, use the service that holds your injection records where you can, so your dose history stays in one place.
Frequently Asked Questions
Can I switch from Wegovy injections to the Wegovy pill?
Yes. Adults on the 2.4 mg weekly injection can move to the 25 mg daily tablet under prescriber supervision, starting seven days after the last injection. For other injection doses, the prescriber chooses the tablet strength because the licence gives no conversion.
How long should I wait between my last injection and my first tablet?
One week. Start the tablet on the day your next injection would have been due.
Can I take the Wegovy pill and the injection together?
No. Both contain semaglutide, so taking them together would double up the medicine. Use one form or the other.
Do I have to start the pill at the lowest dose?
Not if you are on the 2.4 mg injection, because the licence allows a direct move to 25 mg. In every other case, your prescriber decides the starting strength.
Will I lose the same amount of weight on the pill?
Average results were similar in separate trials: 13.6% at 64 weeks for the tablet and 14.9% at 68 weeks for the injection. Individual results vary, and the SmPC says the effect of switching cannot easily be predicted.
Is the Wegovy pill available on the NHS?
Not at the time of writing. It is not currently available on the NHS in England, pending a NICE assessment, so private prescription is the only route for now.
Is the Wegovy pill the same as Rybelsus?
No. Both contain oral semaglutide, but Rybelsus is licensed for type 2 diabetes at doses up to 14 mg, while the Wegovy pill is licensed for weight management at 25 mg.
Can I switch from Mounjaro to the Wegovy pill?
The licence does not cover it. A prescriber would decide the tablet strength and timing after reviewing your current dose, response and side effects.
Can I buy Wegovy pills online without a prescription?
No. It is prescription only, and a legitimate pharmacy will always carry out a consultation and prescriber review first.
The Bottom Line
Adults on the 2.4 mg Wegovy injection can move to the 25 mg Wegovy pill under a prescriber’s supervision, starting seven days after the last injection. In trials, the two produced similar average weight loss, but the tablet asks more of you each morning and is absorbed less predictably. If you are on another injection dose, the licence gives no conversion, so the decision rests with your prescriber. Whichever form you choose, buy only from a GPhC-registered pharmacy after a proper consultation.
This article is for general information and does not replace advice from your prescriber, pharmacist or GP. See more